Pharmacy Industry Updates: February 2020
Every month, our Industry Relations Director, Leann Lewis provides an in-depth industry update to customers. Below, you will find an agenda for the industry update for February. If you have any questions regarding any of the points, contact us here.
Missouri – Effective 12-01-2019
- Require Henry and Washington Counties to report
- Begin Reporting as soon as possible with reporting back to 12-01
- New Data Submission Guide V2.2 effective 01-01-2020 requires Gabapentin Reporting
- Require Diagnosis Code and “reason for the prescription” if provided on the Not included in latest data submission guide
- New format of the 12-digit Serial Number was published for 1-1-20
- 01-01-2021 -Require reporting ”as soon as reasonably possible but no more than one working day after a controlled substance is dispensed.” Also requires Schedule V reporting.
Pennsylvania – Effective 02-28-2020 will require submission of
- Patient Phone Number (PAT17)
- NCPDP ID field (PHA02)
- Transmission Form of Rx Origin Code (DSP12)
- Partial Fill Indicator (DSP13)
- Prescriber State License Number (PRE04) when available)
- New Data Submission Guide is available
Utah – Will be moving to NIC’s RxGov in the future
- 01-15-2020 – Utah still in holding pattern with RxGov
- Require Gabapentin Reporting as of 04-01-2020 but request it be reported ASAP.
Legislative/Regulatory Reminders for February 2020
- Alabama – Updated rules for Collaborative Practice Agreements
New Legislative/Regulatory Highlights
- Massachusetts – Updated EPCS Requirements and exemptions
- New York
- Med sync with full dispensing fee and prorated copays
- Cannot require prior authorization or copay for substance use disorder drugs under most circumstances
- Oregon – Updated compounding rules.
Get Involved/Get Informed Spotlight
- NCPDP Update
- SCRIPT Network compliance progress
- NCPDP Workgroups in Houston Feb 5-7
- Quantity Prescribed Final Rule
- Ohio H.B 166 Section 333.280. Pharmacy Supplemental Dispensing Fee
- PBM Updates
- Update on Rutledge v PCMA – NCPA website for updates
- New York PBM Bill Veto
- 2020 Legislative Outlook
Contact us to ask questions or get more information about these updates.
The organizer of this call is not an attorney, and the presentation on this call does not constitute legal advice. It contains only the opinions and observations of the organizer and its participants. Any use of information contained in this presentation is at the user’s own risk. The organizer will not be available for depositions or testimony in case of litigation.